Resolved to apply for listing on the Fukuoka Stock Exchange (Main Market). The objective is to raise awareness and improve liquidity mainly in the Kyushu region. Timelines and approval status are undecided, and notices will be provided as future disclosures.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6190","jir_company_name":"Phoenix Biotech Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-15","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/6190-20260915-01.pdf","jir_short_summary":"Resolved to apply for listing on the Fukuoka Stock Exchange (Main Market). The objective is to raise awareness and improve liquidity mainly in the Kyushu region. Timelines and approval status are undecided, and notices will be provided as future disclosures.","jir_summary":"### Section Heading\nThis resolution informs that the company, listed on the Tokyo Stock Exchange Growth Market, has decided to apply for duplicate listing on the Fukuoka Stock Exchange (Main Market). The aim is to enhance recognition centered in the Kyushu region, increase individual shareholders, and improve stock liquidity, reflecting a policy to strengthen IR activities and enhance corporate value. At present, the approval timing and feasibility are not determined, and listing is not guaranteed.\n\n### Section 2 Heading\nLooking ahead, this matter is intended for duplicate listing with the Growth Market and will not change the current listing status. If any matters requiring disclosure arise, we will promptly announce them, and the timing of listing approval is undecided.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#PhoenixBiotech, #ListingApplication, #DuplicateListing, #IRInformation","jir_key_figures":"Unknown: Resolution date\nUnknown: Progress status \/ Approval timing\nUnknown: Specific impact indicators of the listing market change","jir_meta_title":"[Phoenix Biotech Co., Ltd.] Resolution for Duplicate Listing Application to Fukuoka Stock Exchange | September 2026","jir_meta_description":"Phoenix Biotech is announcing a board resolution to apply for duplicate listing on the Fukuoka Stock Exchange Main Market. The aim is to improve recognition and liquidity, with the approval timing undecided. Look for future disclosures.","jir_og_title":"[Phoenix Biotech] Resolution for Duplicate Listing Application to Fukuoka Stock Exchange | September 2026","jir_og_description":"Resolution to apply for duplicate listing on the Fukuoka Stock Exchange. Aiming to enhance recognition and stock liquidity in the Kyushu region, but approval timing is undecided.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61189,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-114183","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n